[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Umraniye Education and Research Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":302},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,12,0,[8,45,77,100,123,144,164,183,204,227,250,276],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100576001","dexmedetomidine-and-dexamethasone-added-as-adjuvant-infraclavicular-brachial-plexus-block-in-upper-limb-surgery-100576001",false,"NCT06779604","Dexmedetomidine and Dexamethasone Added as Adjuvant Infraclavicular Brachial Plexus Block in Upper Limb Surgery","Comparison of the Anesthetic Effects of Dexmedetomidine and Dexamethasone Added as Adjuvant to Ultrasonography-Guided Infraclavicular Brachial Plexus Block in Upper Limb Surgery","Inclusion Criteria:\n\n* 18-70 years\n* ASA I-II\n\nExclusion Criteria:\n\n* Under 18 years of age and older than 70 years of age,\n* presence of brachial plexus injury,\n* patients with bleeding diathesis,\n* presence of allergy, -contralateral diaphragmatic paralysis, -\n* presence of nerve injury secondary to trauma,\n* pre-existing neuropathy of the surgical extremity,\n* presence of severe pulmonary,\n* renal and hepatic disease,\n* congestive heart failure (NYHA stage 3-4),\n* uncontrolled diabetes mellitus,\n* history of neuromuscular disease,\n* patients with extreme obesity or malnutrition (BMI \\> 30 kg-1m2 or BMI \\\u003C20 kg-1m2),\n* presence of epilepsy,\n* history of peripheral vascular disease,\n* history of chronic pain or fibromyalgia,\n* pregnant and lactating patients,\n* patients with local infection at the injection site,\n* patients undergoing general anesthesia due to inadequacy of the block,\n* patients refusing to give informed consent,\n* history of recreational substance use, and chronic narcotic-based painkillers","ALL","18 Years","70 Years",{"count":20,"type":21},44,"ESTIMATED","OBSERVATIONAL","The aim of this study was to investigate the effect of dexmedetomidine and dexamethasone added during USG-guided infraclavicular block on block onset time, total block time and time to first analgesic need in patients undergoing upper extremity surgery.",[25,26,27],"Post Operative Pain","Anesthesia","Acute Pain",[29,30,31],"infraclavicular nerve block","dexmetomidine","dexamethosone","RECRUITING","2026-02-16",{"date":35,"type":36},"2026-02-19","ACTUAL",{"date":38,"type":36},"2026-02-01",{"date":40,"type":21},"2026-07-30",{"name":42,"class":43},"Umraniye Education and Research Hospital","OTHER_GOV",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":44},"100614024","paragastric-block-for-pain-and-ponv-in-sleeve-gastrectomy-100614024","NCT07274215","Paragastric Block for Pain and PONV in Sleeve Gastrectomy","Impact of Intraoperative Paragastric Block on Visceral Pain and Postoperative Nausea and Vomiting After Sleeve Gastrectomy: A Randomized Controlled Trial","BLOCK-SG","Inclusion Criteria\n\n* Patients aged between 18 and 65 years.\n* Candidates scheduled for elective LSG.\n* American Society of Anesthesiologists (ASA) physical status classification I-III.\n* Ability to provide written informed consent and willingness to comply with study procedures.\n\nExclusion Criteria\n\n* History of prior upper abdominal surgery.\n* Known psychiatric or neurological disorders that could interfere with pain assessment or postoperative care.\n* History of opioid dependency or chronic opioid use.\n* Allergy or hypersensitivity to local anesthetics or any of the medications used in the study protocol (e.g., paracetamol, dexketoprofen, ondansetron, tramadol, metoclopramide).\n* Severe hepatic, renal, or cardiac dysfunction (e.g., cirrhosis, end-stage renal disease, heart failure).\n* Pregnancy or breastfeeding.\n* Concomitant surgery (e.g., cholecystectomy, hiatal hernia repair, or abdominal wall repair).\n* Known bleeding disorders or coagulopathy (e.g., INR \\>1.5, platelet count \\\u003C50,000\u002Fmm³, or ongoing anticoagulant therapy)","65 Years",{"count":55,"type":21},200,"INTERVENTIONAL",[58],"NA","This single-center, prospective, randomized, double-blind controlled trial aims to evaluate the effects of intraoperative paragastric block (PGBLOCK) on early postoperative visceral pain, postoperative nausea and vomiting (PONV), and analgesic requirements in patients undergoing laparoscopic sleeve gastrectomy (LSG). Despite advancements in multimodal analgesia protocols, visceral pain remains a significant postoperative concern following LSG, contributing to increased opioid use and delayed recovery. Paragastric block is a novel technique targeting autonomic neural pathways-such as branches of the celiac ganglia and vagal nerves-through precise intraoperative injection of local anesthetics near the stomach.\n\nA total of 180 patients scheduled for elective LSG will be randomized in a 1:1 ratio to receive either paragastric block with 20 mL of 0.5% bupivacaine or a sham block with 20 mL of isotonic saline. Injections will be administered at six predefined anatomical sites under laparoscopic guidance after gastric resection. The surgical technique, anesthetic protocol, and postoperative care will be standardized for all participants. Both patients and clinical personnel involved in care and outcome assessment will remain blinded to group assignment.\n\nThe primary outcome is the assessment of postoperative visceral pain using Visual Analog Scale (VAS) scores at 0 and 2 hours postoperatively. Secondary outcomes include PONV severity grading, mobilization status, total analgesic consumption (pethidine + tramadol), and need for rescue antiemetics within the first 24 hours post-surgery. Exclusion criteria include history of upper abdominal surgery, chronic opioid use, pregnancy, severe systemic disease, or allergy to medications used in the protocol.\n\nThis study is expected to provide high-quality evidence regarding the efficacy of paragastric block in improving early postoperative recovery and reducing opioid reliance after LSG.",[61,62],"Postoperative Nausea and Vomiting","Postoperative Pain After Laparoscopic Sleeve Gastrectomy",[64,65,66,67,68],"postoperative pain","postoperative nausea and vomiting","VAS","sleeve gastrectomy","paragastric block","2025-12-10",{"date":71,"type":36},"2025-12-18",{"date":73,"type":36},"2025-10-01",{"date":75,"type":21},"2026-01-20",{"name":42,"class":43},{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":4,"eligibilityCriteria":83,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":53,"enrollmentInfo":84,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":86,"conditions":87,"keywords":89,"overallStatus":91,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":44},"100573612","effects-of-scalp-nerve-block-on-postoperative-pain-hemodynamics-and-surgical-stress-response-in-craniotomy-surgery-100573612","NCT06748547","Effects of Scalp Nerve Block on Postoperative Pain, Hemodynamics and Surgical Stress Response in Craniotomy Surgery","Effects of Scalp Nerve Block on Postoperative Pain, Hemodynamics and Surgical","Inclusion Criteria:\n\n* Age range 18-65\n* ASA 1-3 score\n\nExclusion Criteria:\n\n* Chronic hypertension\n* Arrhythmia\n* body mass index (BMI) over 40 kg\u002Fm2\n* Bleeding diathesis\n* Allergy\n* Serious cardiovascular, pulmonary, renal and hepatic disease\n* Local infection at the injection site\n* Alcohol and substance abuse\n* Neurological sequelae, mental retardation\n* GCS under 15\n* Patients admitted to the intensive care unit as intubated\n* Pregnancy\n* Those with a history of chronic pain\n* Scalp infection\n* Use of vozoactive drugs\n* Patients with previous craniotomy\n* Patients who do not accept",{"count":85,"type":21},64,"The hypothesis of this study is that preincisional scalp nerve block will reduce postoperative opioid use and surgical stress response compared to postincisional scalp nerve block in craniotomy surgery with general anesthesia.",[88,25],"Analgesia",[90],"scalp nerve block,Craniotomy,postoperative pain","NOT_YET_RECRUITING","2025-11-16",{"date":94,"type":36},"2025-11-19",{"date":96,"type":21},"2025-11-30",{"date":98,"type":21},"2026-05-01",{"name":42,"class":43},{"id":101,"slug":102,"hasResults":11,"nctId":103,"briefTitle":104,"officialTitle":105,"acronym":4,"eligibilityCriteria":106,"healthyVolunteers":11,"sex":16,"minAge":53,"maxAge":107,"enrollmentInfo":108,"targetDuration":110,"studyType":22,"phases":4,"briefSummary":111,"conditions":112,"keywords":114,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":117,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":44},"100553200","general-anesthesia-on-blood-pressure-and-intraocular-pressure-in-geriatric-patients-undergoing-cataract-surgery-100553200","NCT06482996","General Anesthesia on Blood Pressure and Intraocular Pressure in Geriatric Patients Undergoing Cataract Surgery","the Impact of General Anesthesia on Blood Pressure and Intraocular Pressure in Geriatric Patients Undergoing Cataract Surgery","Inclusion Criteria:\n\n* 65-85 age\n* ASA I-III\n* cataract surgery with genel anesthesia\n\nExclusion Criteria:\n\n* cerebrovascular disease,\n* mental retardation and psychiatric illness,\n* pulmonary infection, history of advanced COPD or respiratory failure,\n* EF less than 40%, presence of cardiovascular disease,\n* bleeding diathesis,\n* renal and hepatic insufficiency,\n* presence of diabetes mellitus, diuretic\u002Fmannitol users,\n* substance abuse\n* BMI \\>30","85 Years",{"count":109,"type":21},80,"1 Day","The primary aim of the study is to investigate the correlation between preoperative hemodynamics and frailty scores in patients undergoing cataract surgery under general anesthesia. The secondary objective is to explore the relationship between preoperative and postoperative intraocular pressure changes and frailty scores.",[113],"Cataract",[115,116],"Cataract surgery","Frailty",{"date":94,"type":36},{"date":119,"type":36},"2023-10-20",{"date":121,"type":21},"2026-02-27",{"name":42,"class":43},{"id":124,"slug":125,"hasResults":11,"nctId":126,"briefTitle":127,"officialTitle":128,"acronym":4,"eligibilityCriteria":129,"healthyVolunteers":11,"sex":130,"minAge":17,"maxAge":18,"enrollmentInfo":131,"targetDuration":4,"studyType":56,"phases":133,"briefSummary":134,"conditions":135,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":138,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":44},"100553199","the-effects-of-vc-versus-pc-ventilation-on-cerebral-and-respiratory-parameters-in-patients-undergoing-laparoscopic-gynecologic-surgery-100553199","NCT06482983","The Effects of VC Versus PC Ventilation on Cerebral and Respiratory Parameters in Patients Undergoing Laparoscopic Gynecologic Surgery","The Effects of Volume-controlled Ventilation Versus Pressure-controlled Ventilation on Cerebral and Respiratory Parameters in Patients Undergoing Laparoscopic Gynecologic Surgery","Inclusion Criteria:\n\n* 18-70 age\n* ASA 1-3\n\nExclusion Criteria:\n\n* Under 18 years of age, over 70 years of age,\n* ASA IV,\n* history of severe chronic obstructive pulmonary disease (COPD, GOLD III or IV)\n\n  ,-history of severe or uncontrolled bronchial asthma, presence of restrictive lung disease,\n* history of any thoracic surgery operation, need for thoracic drainage before surgery\n* patients receiving preoperative renal replacement therapy,\n* congestive heart failure (NYHA grade III or IV),\n* extremely obese (body Mass Index, BMI \\> 35 Kg\u002Fm2)\n* patients without patient consent","FEMALE",{"count":132,"type":21},120,[58],"The aim of the study was to determine whether the use of different mechanical ventilation modes in patients with Trendelenburg position and CO2 insufflation affects respiration and cerebral oxygenation due to postoperative atelectasis, and was to determine whether there was any hemodynamic effect.",[26,136,137],"Gynecologic Cancer","Mechanical Ventilation Complication",{"date":94,"type":36},{"date":140,"type":36},"2023-05-01",{"date":142,"type":21},"2026-07-31",{"name":42,"class":43},{"id":145,"slug":146,"hasResults":11,"nctId":147,"briefTitle":148,"officialTitle":148,"acronym":4,"eligibilityCriteria":149,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":150,"enrollmentInfo":151,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":153,"conditions":154,"keywords":156,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":159,"startDateStruct":160,"completionDateStruct":162,"leadSponsor":163,"locationsCount":44},"100547241","effects-of-malnutrition-on-respiratory-and-renal-functions-in-patients-undergoing-peroral-endoscopic-myotomy-poem-100547241","NCT06405412","Effects of Malnutrition on Respiratory and Renal Functions in Patients Undergoing Peroral Endoscopic Myotomy (POEM)","Inclusion Criteria:\n\n* Criteria for inclusion in the study:\n* Patients diagnosed with achalasia and suitable for POEM treatment by gastroenterology physicians\n* ASA 1-3\n* Between the ages of 18-80\n\nExclusion Criteria:\n\n* Criteria for exclusion from the study:\n* Those with a known history of active lung infection, advanced COPD, or respiratory failure\n* Patients with EF below 40%, severe ischemic heart failure, presence of valve disease\n* Those with bleeding diathesis and severe thrombocytopenia (limit 30-50 thousand)\n* severe kidney dysfunction\n* In the presence of known intolerance or allergy to certain medications for sedation, analgesia, or both\n* Pre-existing increased intracranial pressure\n* Having a BMI \\>30\n* Severe uncorrected hypovolemiaHistory of radiotherapy to the esophagus\n* History of mucosal resection or ablation in the area where POEM will be applied\n* Presence of cirrhosis and portal hypertension.","80 Years",{"count":152,"type":21},60,"The hypothesis of this study is to investigate cardiorespiratory and renal complications in patients under general anesthesia undergoing POEM surgery.",[155],"Esophageal Achalasia",[157,158,155],"Peroral Endoscopic Myotomy","anesthesia",{"date":94,"type":36},{"date":161,"type":36},"2023-11-01",{"date":40,"type":21},{"name":42,"class":43},{"id":165,"slug":166,"hasResults":11,"nctId":167,"briefTitle":168,"officialTitle":168,"acronym":4,"eligibilityCriteria":169,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":170,"enrollmentInfo":171,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":173,"conditions":174,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":177,"startDateStruct":178,"completionDateStruct":180,"leadSponsor":182,"locationsCount":172},"100547254","the-impact-of-frailty-on-cardiopulmonary-resuscitation-adverse-outcomes-in-patients-requiring-code-blue-activation-100547254","NCT06405581","The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation","Inclusion Criteria:\n\n* pediatric patients\n\nExclusion Criteria:\n\n* pregnant patients","100 Years",{"count":172,"type":21},2,"The aim of this study was to determine the independent association of frailty with cardiopulmonary resuscitation and predictive factors in patients triggering code blue response",[175,116,176],"Cardiac Arrest","Respiratory Arrest",{"date":94,"type":36},{"date":179,"type":21},"2025-12-01",{"date":181,"type":21},"2026-05-30",{"name":42,"class":43},{"id":184,"slug":185,"hasResults":11,"nctId":186,"briefTitle":187,"officialTitle":188,"acronym":4,"eligibilityCriteria":189,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":107,"enrollmentInfo":190,"targetDuration":4,"studyType":56,"phases":192,"briefSummary":193,"conditions":194,"keywords":196,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":198,"startDateStruct":199,"completionDateStruct":201,"leadSponsor":203,"locationsCount":44},"100530594","investigation-of-the-effect-of-proximal-and-distal-adductor-canal-block-in-knee-replacement-surgery-100530594","NCT06188806","Investigation of the Effect of Proximal and Distal Adductor Canal Block in Knee Replacement Surgery","Investigation of the Effect of Proximal and Distal Adductor Canal Block on Pain Control and Functional Mobility in Total Knee Prosthesis Surgery Performed Under Spinal Anesthesia","Inclusion Criteria:\n\n* Medications for unilateral TKA surgery\n\n  * Patients aged 18-85\n  * ASA 1-3\n\nExclusion Criteria:\n\n* Patients under 18 years of age and over 85 years of age\n* Patients with ASA 4 and above\n* Patients with cognitive impairment\n* Patients with application site infection\n* Patients allergic to local anesthesia\n* Patients receiving anticoagulant therapy\n* Patients with bleeding diathesis\n* Patients with chronic opioid or substance use\n* Patients with insulin-dependent diabetes mellitus\n* patients with neuropathy\n\n  * patients with hepatic or renal failure\n* Patients who do not accept the procedure to be applied",{"count":191,"type":21},78,[58],"to investigate the effect of adductor canal block applied with two different approaches in the treatment of pain after TKA surgery on pain control and functional mobility.",[195],"Knee Osteoarthritis",[197],"adduktor canal block,knee artroplasti,postoperative pain",{"date":94,"type":36},{"date":200,"type":36},"2023-11-10",{"date":202,"type":21},"2026-03-30",{"name":42,"class":43},{"id":205,"slug":206,"hasResults":11,"nctId":207,"briefTitle":208,"officialTitle":208,"acronym":4,"eligibilityCriteria":209,"healthyVolunteers":11,"sex":16,"minAge":210,"maxAge":107,"enrollmentInfo":211,"targetDuration":4,"studyType":56,"phases":212,"briefSummary":213,"conditions":214,"keywords":216,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":221,"startDateStruct":222,"completionDateStruct":224,"leadSponsor":226,"locationsCount":44},"100530188","effects-of-pericapsular-nerve-group-block-on-postoperative-recovery-for-total-hip-arthroplasty-100530188","NCT06183528","Effects of Pericapsular Nerve Group Block on Postoperative Recovery for Total Hip Arthroplasty","Inclusion Criteria:\n\n* THA performed by posterior approach\n* 40-85 age range\n* ASA 1-3\n\nExclusion Criteria:\n\nUnder 40 years of age, over 85 years of age,\n\n* ASA 4 and above,\n* Cognitive impairment (Alzheimer's disease, dementia, delirium etc.),\n* Hip fracture,\n* Application site infection,\n* Allergy to local anaesthetic agents,\n* Patients are non-consenting patients.","40 Years",{"count":152,"type":21},[58],"The hypothesis of this study is that patients who undergo PENG block in before Total Hip Artroplasthy (THA) surgery with spinal anesthesia will have reduced postoperative pain scores, less need for opioid analgesics and earlier mobilisation.",[88,215],"Postoperative Pain, Acute",[217,218,219,220],"Multimodal analgesia","pericapsular nerve group block","total hip arthroplasty","spinal anesthesia",{"date":94,"type":36},{"date":223,"type":36},"2023-09-01",{"date":225,"type":21},"2025-12-30",{"name":42,"class":43},{"id":228,"slug":229,"hasResults":11,"nctId":230,"briefTitle":231,"officialTitle":232,"acronym":4,"eligibilityCriteria":233,"healthyVolunteers":11,"sex":16,"minAge":234,"maxAge":107,"enrollmentInfo":235,"targetDuration":4,"studyType":56,"phases":237,"briefSummary":238,"conditions":239,"keywords":242,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":244,"startDateStruct":245,"completionDateStruct":247,"leadSponsor":249,"locationsCount":172},"100530189","effects-of-pericapsular-nerve-group-block-applied-in-patients-undergoing-hip-fracture-surgery-100530189","NCT06183541","Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery.","Effects of Pericapsular Nerve Group (PENG) Block Applied for Analgesia on the Postoperative Process in Patients Undergoing Hip Fracture Surgery.","Inclusion Criteria:\n\n* Patients who will undergo hip fracture surgery Women and men aged 30-85\n\nExclusion Criteria:\n\n* Patients under 30 years old, over 85 years old\n* American Society of Anesthesiology (ASA) IV,\n* Those with cognitive impairment (alzheimer, dementia, delirium, etc.)\n* Those with application site infection\n* Those who are allergic to local anesthetic substances\n* Patients are non-consenting patients.","30 Years",{"count":236,"type":21},70,[58],"In this study, it was aimed to compare the multimodal analgesia application or the pericapsular nerve group (PENG) block methods in patients undergoing hip surgery. The effectiveness and benefit rate of the PENG block in postoperative pain will be evaluated.\n\nPostoperative pain, need for additional analgesia, range of motion of the hip joint, mobilization time, length of hospital time and adverse events in patients undergoing hip fracture surgery with and without PENG block will be investigated.",[240,241],"Hip Fractures","Pain, Postoperative",[243,26],"PENG block",{"date":94,"type":36},{"date":246,"type":36},"2023-11-21",{"date":248,"type":21},"2026-01-30",{"name":42,"class":43},{"id":251,"slug":252,"hasResults":11,"nctId":253,"briefTitle":254,"officialTitle":255,"acronym":4,"eligibilityCriteria":256,"healthyVolunteers":11,"sex":16,"minAge":257,"maxAge":18,"enrollmentInfo":258,"targetDuration":4,"studyType":56,"phases":260,"briefSummary":261,"conditions":262,"keywords":266,"overallStatus":91,"whyStopped":4,"lastUpdateSubmitDate":268,"lastUpdatePostDateStruct":269,"startDateStruct":271,"completionDateStruct":273,"leadSponsor":275,"locationsCount":44},"100583057","low-and-moderete-flow-anaesthesia-on-haemodynamics-100583057","NCT06871371","Low and Moderete Flow Anaesthesia on Haemodynamics","The Comparison of the Effects of Low and Medium Flow Anesthesia on Haemodynamics, Arrhytmia Risk and Cerebral Oxygenation in Laparoscopic Cholecystomy Cases","Inclusion Criteria:\n\n* being ASA1-2 status\n* between the ages of 18-70\n* who are planned for laparoscopic cholecystectomy\n\nExclusion Criteria:\n\n* Patients who refuse to give informed consent\n* Pregnant and breastfeeding patients\n* Morbidly obese patients (Body mass index over 40)\n* Patients with uncontrolled diabetes mellitus, with serious cardiovascular, pulmonary, renal, hepatic disease, obstructive sleep apnea, with electrolyte imbalance- Those with a history of alcohol or drug abuse, with perioperative hemodynamic instability\n* Patients using drugs known to prolong myocardial repolarization\n* inability to increase SPO2 above 95 despite necessary intervention","17 Years",{"count":259,"type":21},76,[58],"The study topic investigates the potential advantages of low-flow anesthesia in terms of physiological protection and resource saving.",[263,264,265],"Hemodynamics Instability","Arrhythmias Cardiac","Cerebral Oxygenation",[267],"Low-Medium Flow Anesthesia, Hemodynamics, Oxygenation","2025-03-06",{"date":270,"type":36},"2025-03-11",{"date":272,"type":21},"2025-03-15",{"date":274,"type":21},"2025-04-15",{"name":42,"class":43},{"id":277,"slug":278,"hasResults":11,"nctId":279,"briefTitle":280,"officialTitle":281,"acronym":4,"eligibilityCriteria":282,"healthyVolunteers":283,"sex":16,"minAge":17,"maxAge":284,"enrollmentInfo":285,"targetDuration":4,"studyType":56,"phases":287,"briefSummary":288,"conditions":289,"keywords":291,"overallStatus":91,"whyStopped":4,"lastUpdateSubmitDate":294,"lastUpdatePostDateStruct":295,"startDateStruct":297,"completionDateStruct":299,"leadSponsor":301,"locationsCount":4},"100569544","effectiveness-of-bilateral-endoscopic-sphenopalatine-ganglion-block-on-postoperative-pain-after-septoplasty-100569544","NCT06695624","Effectiveness of Bilateral Endoscopic Sphenopalatine Ganglion Block on Postoperative Pain After Septoplasty","Investigation of the Effectiveness of Bilateral Endoscopic Sphenopalatine Ganglion Block in Management of Postoperative Pain After Septoplasty","Inclusion Criteria:\n\n* Participants who will undergo septoplasty\n* 18 to 50 years old\n* ASA score 1 or 2\n\nExclusion Criteria:\n\n* Under 18 or over 50 years of age\n* ASA score III and above patient group\n* The patient is allergic to any of the drugs used\n* The patient has a contraindication to any of the drugs used\n* Use of anticoagulant medication\n* Failure of the patient to give consent\n* Being pregnant\n* Those with GCS retardation such as dementia, mental retardation\n* Those with diagnosed headache",true,"50 Years",{"count":286,"type":21},50,[58],"The aim of this clinical study will investigate the efficacy of sphenopalatine ganglion block in the treatment of postoperative pain.it will also be learnt whether it reduces the consumption of analgesics in postoperative pain.The main questions it aims to answer are:\n\nWill the participants' need for painkillers decrease after the operation? Can sphenopalatine ganglion block be used for postoperative pain after septoplasty? The researchers will compare 2 groups with and without sphenopalatine ganglion block to see the effectiveness of sphenopalatine ganglion block.\n\nParticipants will:\n\nRead the information Participants have been given about the sphenopalatine ganglion block.\n\nIn case of any side effects, please contact participant's doctor.",[290],"Postoperative Pain",[292,293,64],"sphenopalatine ganglion block","septoplasty","2024-11-15",{"date":296,"type":36},"2024-11-19",{"date":298,"type":21},"2024-11",{"date":300,"type":21},"2025-01",{"name":42,"class":43},""]